FIELD: medicine.
SUBSTANCE: invention refers to treating subacute venous thrombosis of various localisations. Dabigatran "Paradaksa" drug is administered in an individually selected dose, which is defined as providing level of thrombin time of 100-200 seconds 2 hours after administration. Treatment is carried out for 2-4 months, maintaining specified level of thrombin time. Then treatment switches to a preventive dose which provides thrombin time 50-100 seconds.
EFFECT: method provides effective treatment of subacute venous thrombosis of various localisations, including resistance to anticoagulant therapy, carried out using other existing methods, owing to individual selection of effective doses.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ACUTE VENOUS THROMBOSES OF VARIOUS LOCALISATIONS WITH UNDERLYING HEMORRHAGIC COMPLICATIONS | 2012 |
|
RU2477636C1 |
| METHOD FOR ANTICOAGULANT THERAPY AND PREVENTION OF THROMBOTIC COMPLICATIONS IN PATIENTS WITH SEVERE BRAIN DAMAGE IN A CHRONIC CRITICAL CONDITION | 2021 |
|
RU2762945C1 |
| METHOD FOR TREATMENT AND PREVENTION OF RECURRENT VENOUS THROMBOSIS AFTER THE NOVEL CORONAVIRUS INFECTION | 2022 |
|
RU2791373C1 |
| ANTICOAGULANT DRUG, WHICH IS A SYNTHETIC DIPEPTIDE Ac-Trp-Arg-Pip·HCl, A PHARMACEUTICAL COMPOSITION COMPRISING SAID ANTICOAGULANT DRUG | 2019 |
|
RU2712194C1 |
| METHOD FOR RECANALISATION OF LATERAL SINUSES IN THROMBOSES OF OTOGENIC ETIOLOGY IN CHILDREN | 2020 |
|
RU2758759C1 |
| METHOD FOR PRESCRIBING INDIVIDUAL ANTITHROMBOTIC THERAPY IN ACUTE AND EARLY PERIODS OF SPINOCRONOUS INJURY OF THE CERVICAL SPINE | 2021 |
|
RU2770633C1 |
| PERSONALIZED METHOD OF TREATING VEIN THROMBOSIS OF LOWER EXTREMITIES IN WOUNDED | 2023 |
|
RU2813947C1 |
| METHOD OF PREVENTION OF BLEEDING CAUSED BY USE OF DABIGATRAN ETEXILATE IN EXPERIMENT | 2013 |
|
RU2552331C1 |
| METHOD FOR THROMBECTOMY FROM THE LOWER CAVITY VINA IN ACUTE UPLREADING FLOATING DRIFT THROMBOSES | 2020 |
|
RU2746606C1 |
| METHOD FOR PREVENTING THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH MULTIPLE FRACTURES OF LIMB LONG BONES | 2019 |
|
RU2726358C1 |
